[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections].
Iakovlev
V P
VP
A. V. Vishnevsky Institute of Surgery, Russian Academy of Medical Science, Moscow.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D017291:Clarithromycin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D014018:Tissue Distribution
D000900:Anti-Bacterial Agents; D017291:Clarithromycin